PFE: Pfizer Corporation Price-to-Revenue Multiple

Symbol and logo of brand Pfizer Corp (PFE)

Pfizer Inc. (PFE) minimizes risks through a broad portfolio of vaccines and oncology drugs. The company's P/S ratio reflects valuation dynamics relative to sales, where the 2.60 mark characterizes this parameter. The holding is implementing "green chemistry" to reduce production toxicity. Business stability relies on patent protection and government healthcare spending.

Pfizer Corp (PFE) - P/S Multiple from 07/04/2022 to 11/13/2026

Pfizer Corporation (PFE) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price pfizer.com|PFE - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Pfizer Corporation|PFE - Total Company Value
- book capitalization data:
Share Book Value Pfizer|PFE - Book Capitalization|Market Capitalization to Net Assets pfizer.com|PFE - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Pfizer Inc.|PFE - Long-Term Debt to Equity Ratio|Current Liabilities to Equity Pfizer Corp|PFE - Company Aggregate Debts|Debts to Book Value Pfizer Corporation|PFE - Company Long-Term Debt|Company Short-Term Loans and Borrowings Pfizer|Intermediate Coverage Ratio pfizer.com
- earnings and valuation multiples indicators:
PFE - Net Profit|Company Profit Forecast Pfizer Inc.|PFE - Price to Earnings Ratio|Price to Future Earnings Ratio Pfizer Inc|PFE - PEG Multiple|Enterprise Value to EBITDA Ratio Pfizer Corporation|PFE - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Pfizer|PFE - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months pfizer.com|PFE - Earnings growth in current year|Net earnings per share change forecast for next year Pfizer Inc.
- issuer revenue and sales details:
PFE - Revenue and Sales Volume|Company Expected Sales Volume pfizer.com|PFE - Price-to-Revenue Ratio|Future Price to Revenue Pfizer Corporation
General company analysis:PFE - pfizer.com
Core merchandise of Pfizer Inc

To protect capital from market volatility, it is essential for investors to correlate the market value of Pfizer Inc. (PFE) with its actual earnings. The company's global distribution scale and government contracts ensure revenue stability, making the price-to-sales ratio a key valuation tool: this metric indicates how many dollars of market capitalization are attributed to each unit of sales, helping to determine the asset's degree of overvaluation and avoid excessive portfolio risks.

Competitors of Pfizer Inc.

lilly.com - Market Cap to Revenue Ratio|P/S Multiple ABBV (AbbVie)|Price-to-Revenue Multiple AstraZeneca Plc|NVS - Price-to-Revenue Ratio|Price-to-Sales Ratio MRK|NVO: P/S Multiple|Price-to-Sales Ratio AMGN (amgen.com)|SNY (Sanofi S.A.) - P/S Multiple|Bristol Myers Squibb Company (BMY) - Price-to-Revenue Coefficient|Market Cap to Revenue GSK (GSK plc)|TAK: Price-to-Sales Ratio|P/S Multiple TEVA (Teva Pharmaceutical Industries)|drreddys.com (RDY) - Price to Sales|VTRS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio ROIV (Roivant)|ZLAB (Zai Lab Ltd.) - Market Cap to Revenue|Bausch Health Corp - Market Capitalization-to-Revenue Ratio|COSM (Cosmos Health Inc.) - P/S Multiple